Lifevantage CorpLFVNEarnings & Financial Report
Lifevantage Corp is a health and wellness enterprise that develops, manufactures and distributes science-backed nutritional supplements, skincare and personal care products. It operates via a direct-to-consumer network marketing model, serving customers across North America, Europe and the Asia-Pacific, with focus on anti-aging and holistic health solution segments.
LFVN Q2 FY2026 Key Financial Metrics
Revenue
$48.9M
Gross Profit
$36.2M
Operating Profit
$487.0K
Net Profit
$276.0K
Gross Margin
74.0%
Operating Margin
1.0%
Net Margin
0.6%
YoY Growth
-27.8%
EPS
$0.02
Lifevantage Corp Q2 FY2026 Financial Summary
Lifevantage Corp reported revenue of $48.9M (down 27.8% YoY) for Q2 FY2026, with a net profit of $276.0K (down 89.2% YoY) (0.6% margin). Cost of goods sold was $12.7M, operating expenses totaled $35.7M.
Key Financial Metrics
| Total Revenue | $48.9M |
|---|---|
| Net Profit | $276.0K |
| Gross Margin | 74.0% |
| Operating Margin | 1.0% |
| Report Period | Q2 FY2026 |
Lifevantage Corp Annual Revenue by Year
Lifevantage Corp annual revenue history includes year-by-year totals (for example, 2025 revenue was $228.5M).
Lifevantage Corp Quarterly Revenue & Net Profit History
Lifevantage Corp results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q2 FY2026 | $48.9M | -27.8% | $276.0K | 0.6% |
| Q1 FY2026 | $47.6M | +0.7% | $2.2M | 4.5% |
| Q4 FY2025 | $55.1M | +12.6% | $2.0M | 3.6% |
| Q3 FY2025 | $58.4M | +21.1% | $3.5M | 5.9% |
| Q2 FY2025 | $67.8M | +31.3% | $2.5M | 3.8% |
| Q1 FY2025 | $47.2M | -8.1% | $1.8M | 3.9% |
| Q4 FY2024 | $48.9M | -9.8% | $1.3M | 2.7% |
| Q3 FY2024 | $48.2M | -10.2% | $1.7M | 3.4% |
Income Statement
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $48.2M | $48.9M | $47.2M | $67.8M | $58.4M | $55.1M | $47.6M | $48.9M |
| YoY Growth | -10.2% | -9.8% | -8.1% | 31.3% | 21.1% | 12.6% | 0.7% | -27.8% |
Balance Sheet
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $61.3M | $60.3M | $61.5M | $68.5M | $77.2M | $72.0M | $61.6M | $61.2M |
| Liabilities | $34.5M | $34.3M | $33.8M | $38.6M | $43.2M | $37.3M | $28.4M | $28.2M |
| Equity | $26.8M | $26.0M | $27.7M | $29.9M | $34.0M | $34.6M | $33.2M | $33.0M |
Cash Flow
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $3.1M | $2.6M | $-583000 | $9.2M | $2.2M | $1.0M | $-2.3M | $2.8M |